nach oben

Erschienen in:

01.06.2019 | News item

Health Canada: cancer risk with gentian violet products?

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Exposure to human health products containing gentian violet (methylrosanilinium chloride) may increase the potential risk of cancer, warns Health Canada. …

Health Canada. Summary Safety Review - Gentiane Violet Liquid Topical (gentian violet) and Hydrofera Antibacterial Foam Dressings - Health Canada. Internet Document : 12 Jun 2019. Available from: URL: https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&linkID=SSR00224

Titel: Health Canada: cancer risk with gentian violet products?
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63891-8

Diclofenamide

Case report

Springer Medizin

Health Canada: cancer risk with gentian violet products?

Excerpt

Weitere Artikel der Ausgabe 1/2019

Diclofenamide

Meningococcal vaccine groups A-C-Y-W-135 conjugate/Meningococcal vaccine groups A-C-Y-W-135 polysaccharide

Betamethasone-dipropionate

Somatrogon

Multiple drugs

Sodium valproate

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Diclofenamide

Meningococcal vaccine groups A-C-Y-W-135 conjugate/Meningococcal vaccine groups A-C-Y-W-135 polysaccharide

Betamethasone-dipropionate

Somatrogon

Multiple drugs

Sodium valproate